Calendar Enlivex Therapeutics Ltd.

Equities

ENLV

IL0011319527

Market Closed - Nasdaq 21:00:00 26/04/2024 BST 5-day change 1st Jan Change
1.44 USD -0.69% Intraday chart for Enlivex Therapeutics Ltd. +9.09% -46.67%

Chart calendar Enlivex Therapeutics Ltd.

ad0a395b84bd8ca1710c607953194f3.Xo7eVgOkwyQGbm1PTGnyxrUPuBcFxnngiC6qpk_1CBc.O_7pH0rpp0Y2Bj8mDl29guJ1-kcymSzWw2mH7QKSaWAZxa5jSO-0Q2UCPA~9f41b7837640e80f9cda71696177243a

Upcoming events on Enlivex Therapeutics Ltd.

23/05/2024 Q1 2024 Earnings Release (Projected)
22/05/2025 Q1 2025 Earnings Release (Projected)

Past events on Enlivex Therapeutics Ltd.

12/04/2024 13:30 Allocetra Phase II Trial Results Call
20/03/2024 RedChip Investor Group Call
12/09/2023 22:00 H.C. Wainwright Global Investment Conference
26/06/2023 13:00 Q1 2023 Earnings Release
09/06/2023 16:30 Jefferies Global Healthcare Conference
01/06/2023 17:00 International Society for Cell & Gene Therapy Meeting - Poster No:1057
01/06/2023 17:00 International Society for Cell & Gene Therapy Meeting - Poster No:1003
31/05/2023 18:00 International Society for Cell & Gene Therapy Meeting - Poster No:805
05/12/2022 13:00 Q3 2022 Earnings Release
09/11/2022 Society for Immunotherapy of Cancer Meeting
06/10/2022 19:30 Macrophage directed Therapies Summit
15/09/2022 14:20 Cantor Cell and Genetic Medicines Conference - Panel
14/09/2022 20:10 Baird Global Healthcare Conference
13/09/2022 16:00 H.C. Wainwright Global Investment Conference
11/09/2022 European Society for Medical Oncology
22/08/2022 13:00 Interim 2022 Earnings Release
09/06/2022 18:00 Jefferies Healthcare Conference
05/06/2022 14:00 American Society of Clinical Oncology Meeting
22/05/2022 H.C. Wainwright Global Investment Conference - Pre-Recorded
29/04/2022 13:41 FY 2021 Earnings Release

Annual results

Fiscal PeriodDecember 2019 2020 2021 2022 2023 2024
Net sales
Million USD
Released
Forecast
Spread
0,00
0,00
-
0,00
0,00
-
0,00
0,00
-
0,00
0,00
-
0,00
0,00
-

0,00

EBITDA
Released
Forecast
Spread
0,00
0,00
-
0,00
0,00
-
0,00
0,00
-
0,00
0,00
-
0,00
0,00
-

0,00

EBIT
Million USD
Released
Forecast
Spread
-8,62
-8,08
-6.67%
-9,79
-8,79
-11.35%
-19,3
-17,0
-13.73%
-25,8
-24,0
-7.7%
-29,4
-23,8
-23.72%

-16,3

Earnings before Tax (EBT)
Million USD
Released
Forecast
Spread
0,00
0,00
-
0,00
0,00
-
-14,5
-15,6
7.04%
-31,1
-30,9
-0.61%
-29,1
-25,2
-15.47%

-16,3

Net income
Million USD
Released
Forecast
Spread
0,00
0,00
-
0,00
0,00
-
-14,5
-15,6
7.04%
-31,1
-30,9
-0.61%
-29,1
-25,2
-15.47%

-16,3

EPS
USD
Released
Forecast
Spread
0,00
0,00
-
0,00
0,00
-
-0,81
-0,86
5.81%
-1,69
-1,68
-0.6%
-1,56
-1,36
-14.71%

-0,86

Announcement Date30/04/2030/04/2129/04/2231/03/2329/03/24-

Quarterly results

Fiscal PeriodDecember 2021 Q4 2022 Q1 2022 Q2 2022 Q3 2022 Q4 2023 Q1 2023 Q2 2023 Q3 2023 Q4 2024 Q1 2024 Q2 2024 Q3 2024 Q4 2025 Q1
Net sales
Million USD
Released
Forecast
Spread
0,00
0,00
-
0,00
0,00
-
0,00
0,00
-
0,00
0,00
-
0,00
0,00
-
0,00
0,00
-
0,00
0,00
-
0,00
0,00
-
0,00
0,00
-

0,00


0,00


0,00


0,00




EBIT
Million USD
Released
Forecast
Spread
-7,81
-4,85
-61.11%
-6,40
-8,10
20.94%
-5,87
-7,70
23.75%
-5,68
-5,30
-7.11%
-7,85
-6,00
-30.75%
-6,78
-7,30
7.08%
-6,65
-7,00
5.01%
-5,63
-6,00
6.2%
-10,3
-4,70
-119.89%

-4,60


-4,40


-3,80


-3,50




Earnings before Tax (EBT)
Million USD
Released
Forecast
Spread
-4,74
-5,31
10.81%
-8,23
-7,59
-8.44%
-9,91
-8,20
-20.89%
-5,73
-5,31
-8.05%
-7,19
-7,00
-2.7%
-7,22
-7,31
1.19%
-6,79
-8,00
15.1%
-5,96
-6,01
0.72%
-9,10
-5,20
-74.9%

-4,60


-4,40


-3,80


-3,50




Net income
Million USD
Released
Forecast
Spread
-4,74
-5,31
10.81%
-8,23
-7,59
-8.44%
-9,91
-8,20
-20.89%
-5,73
-5,31
-8.05%
-7,19
-7,00
-2.7%
-7,22
-7,31
1.19%
-6,79
-8,00
15.1%
-5,96
-6,01
0.72%
-9,10
-5,20
-74.9%

-4,60


-4,40


-3,80


-3,50




EPS
USD
Released
Forecast
Spread
-0,26
-0,28
7.14%
-0,45
-0,41
-9.76%
-0,54
-0,45
-20%
-0,31
-0,29
-6.9%
-0,39
-0,38
-2.63%
-0,39
-0,40
2.5%
-0,37
-0,43
13.95%
-0,32
-0,32
0%
-0,48
-0,28
-71.43%

-0,25


-0,24


-0,20


-0,17


-0,14

Announcement Date29/04/2227/05/2222/08/2202/12/2231/03/2316/06/2301/09/2309/11/2329/03/24-----

Net sales - Quarter - Rate of surprise

Quarterly earnings - Rate of surprise

Net sales - Annual - Rate of surprise

Annual profits - Rate of surprise

  1. Stock Market
  2. Equities
  3. ENLV Stock
  4. Calendar Enlivex Therapeutics Ltd.